AR026986A1 - Implante farmaceutico con contenido de componentes de liberacion inmediata y liberacion sostenida y metodos de administracion - Google Patents
Implante farmaceutico con contenido de componentes de liberacion inmediata y liberacion sostenida y metodos de administracionInfo
- Publication number
- AR026986A1 AR026986A1 ARP000106698A ARP000106698A AR026986A1 AR 026986 A1 AR026986 A1 AR 026986A1 AR P000106698 A ARP000106698 A AR P000106698A AR P000106698 A ARP000106698 A AR P000106698A AR 026986 A1 AR026986 A1 AR 026986A1
- Authority
- AR
- Argentina
- Prior art keywords
- release
- implant
- sustained release
- sustained
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un implante farmacéutico para administrar una sustancia biologicamente activa se compone de un componente de liberacion inmediata, que preferentementecontiene un agente desintegrante y un componente de liberacion sostenida. El implante de la presente invencion confiere flexibilidad para regular la liberacionsostenida. El implante de la presente invencion confiere flexibilidad para regular la liberacion del medicamento y se puede producir uncomienzo de la accionmás rápido junto con una liberacion sostenida a largo plazo. La velocidad de liberacion de la sustancia biologicamente activa puede ser ajustada controlandolas cantidades relativas del componente de liberacion inmediata y del componente de liberacion sostenida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17121599P | 1999-12-16 | 1999-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR026986A1 true AR026986A1 (es) | 2003-03-05 |
Family
ID=22622955
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000106698A AR026986A1 (es) | 1999-12-16 | 2000-12-15 | Implante farmaceutico con contenido de componentes de liberacion inmediata y liberacion sostenida y metodos de administracion |
Country Status (12)
Country | Link |
---|---|
US (1) | US20020131988A1 (es) |
EP (1) | EP1237556A2 (es) |
JP (1) | JP2003517014A (es) |
KR (1) | KR100715748B1 (es) |
AR (1) | AR026986A1 (es) |
AU (1) | AU783538B2 (es) |
BR (1) | BR0016012A (es) |
CA (1) | CA2391957A1 (es) |
MX (1) | MXPA02005911A (es) |
NZ (1) | NZ519575A (es) |
WO (1) | WO2001043749A2 (es) |
ZA (1) | ZA200204352B (es) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6953586B1 (en) * | 2000-06-08 | 2005-10-11 | Ivy Animal Health, Inc. | Growth promoting pharmaceutical implant |
AUPR602501A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release pharmaceutical composition |
US20030068375A1 (en) * | 2001-08-06 | 2003-04-10 | Curtis Wright | Pharmaceutical formulation containing gelling agent |
GB2379390B (en) * | 2001-09-11 | 2005-01-26 | Caretek Medical Ltd | A novel drug delivery technology |
DE10164510A1 (de) * | 2001-12-20 | 2003-07-10 | Schering Ag | Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes |
AU2003201410B2 (en) * | 2002-01-24 | 2008-07-03 | Virbac Corporation | Sustained release pharmaceutical composition |
US9101540B2 (en) * | 2002-04-12 | 2015-08-11 | Alkermes Pharma Ireland Limited | Nanoparticulate megestrol formulations |
US20040105889A1 (en) * | 2002-12-03 | 2004-06-03 | Elan Pharma International Limited | Low viscosity liquid dosage forms |
HUE037643T2 (hu) | 2004-06-12 | 2018-09-28 | Collegium Pharmaceutical Inc | Visszaélésre nem alkalmas gyógyszerkészítmények |
CA2575988C (en) | 2004-08-04 | 2014-02-18 | Brookwood Pharmaceuticals, Inc. | Methods for manufacturing delivery devices and devices thereof |
US20080102123A1 (en) * | 2006-10-27 | 2008-05-01 | Schachter Deborah M | Self-gelling tunable drug delivery system |
US8470360B2 (en) * | 2008-04-18 | 2013-06-25 | Warsaw Orthopedic, Inc. | Drug depots having different release profiles for reducing, preventing or treating pain and inflammation |
EP2222281B1 (en) | 2007-12-20 | 2018-12-05 | Evonik Corporation | Process for preparing microparticles having a low residual solvent volume |
US8889173B2 (en) * | 2008-04-18 | 2014-11-18 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of pain and/or inflammation |
US8956641B2 (en) * | 2008-04-18 | 2015-02-17 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of inflammatory diseases |
US20100015049A1 (en) * | 2008-07-16 | 2010-01-21 | Warsaw Orthopedic, Inc. | Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents |
WO2010144849A2 (en) * | 2009-06-11 | 2010-12-16 | Medtronic, Inc. | Dissolvable pharmaceutical implant |
US9399018B2 (en) * | 2009-09-17 | 2016-07-26 | Evonik Corporation | Implant devices that differ by release profile and methods of making and using same |
US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
US8758799B2 (en) * | 2010-03-24 | 2014-06-24 | Covidien Lp | Therapeutic implant |
US8758800B2 (en) * | 2010-03-24 | 2014-06-24 | Covidien Lp | Therapeutic implant |
US8758798B2 (en) | 2010-03-24 | 2014-06-24 | Covidien Lp | Therapeutic implant |
US9375437B2 (en) | 2010-06-18 | 2016-06-28 | Lipocine Inc. | Progesterone containing oral dosage forms and kits |
US20110312927A1 (en) * | 2010-06-18 | 2011-12-22 | Satish Kumar Nachaegari | Progesterone Containing Oral Dosage Forms and Related Methods |
US9211175B2 (en) | 2010-07-08 | 2015-12-15 | Covidien Lp | Self-detachable medical devices |
FR2962646B1 (fr) | 2010-07-16 | 2012-06-22 | Sofradim Production | Prothese avec element radio-opaque |
US9572907B2 (en) | 2010-10-01 | 2017-02-21 | Covidien Lp | Implantable polymeric films |
US8632839B2 (en) | 2010-10-19 | 2014-01-21 | Covidien Lp | Methods of forming self-supporting films for delivery of therapeutic agents |
US9861590B2 (en) | 2010-10-19 | 2018-01-09 | Covidien Lp | Self-supporting films for delivery of therapeutic agents |
US8920867B2 (en) | 2010-10-19 | 2014-12-30 | Covidien Lp | Methods of forming self-supporting films for delivery of therapeutic agents |
US9144634B2 (en) | 2011-01-14 | 2015-09-29 | Covidien Lp | Medical device with intrapore films |
FR2977790B1 (fr) | 2011-07-13 | 2013-07-19 | Sofradim Production | Prothese pour hernie ombilicale |
US8579924B2 (en) | 2011-07-26 | 2013-11-12 | Covidien Lp | Implantable devices including a mesh and a pivotable film |
US8951996B2 (en) | 2011-07-28 | 2015-02-10 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
US9782957B2 (en) | 2011-08-24 | 2017-10-10 | Covidien Lp | Medical device films |
US8932621B2 (en) | 2011-10-25 | 2015-01-13 | Covidien Lp | Implantable film/mesh composite |
US9005308B2 (en) | 2011-10-25 | 2015-04-14 | Covidien Lp | Implantable film/mesh composite for passage of tissue therebetween |
US9179994B2 (en) | 2011-10-25 | 2015-11-10 | Covidien Lp | Implantable film/mesh composite |
US10206769B2 (en) | 2012-03-30 | 2019-02-19 | Covidien Lp | Implantable devices including a film providing folding characteristics |
FR2992662B1 (fr) | 2012-06-28 | 2014-08-08 | Sofradim Production | Tricot avec picots |
FR2992547B1 (fr) | 2012-06-29 | 2015-04-24 | Sofradim Production | Prothese pour hernie |
MX2017016823A (es) | 2015-06-22 | 2018-03-12 | Lipocine Inc | Composiciones orales que contienen éster de 17- hydroxiprogesterona y métodos relacionados. |
WO2017105512A1 (en) | 2015-12-18 | 2017-06-22 | Proinvet Innovations S.A. | Formulations and methods for controlling the reproductive cycle and ovulation |
US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
CN110251737A (zh) * | 2019-08-06 | 2019-09-20 | 湖南优感觉生物科技有限公司 | 一种添加了玻尿酸的乳胶避孕套 |
EP4000688A1 (en) | 2020-11-19 | 2022-05-25 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of trenbolone acetate having a definite particle size distribution |
EP4001288A1 (en) | 2020-11-19 | 2022-05-25 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit |
ES2948624T3 (es) | 2020-11-19 | 2023-09-14 | Fis Fabbrica Italiana Sintetici Spa | Proceso mejorado para la preparación de trembolona y/o acetato de trembolona |
EP4037666B1 (en) | 2020-12-08 | 2024-05-01 | Ruminant Biotech Corp Limited | Improvements to devices and methods for delivery of substances to animals |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3417182A (en) * | 1963-03-25 | 1968-12-17 | Upjohn Co | Compositions and treatments using 6-methyl - 16 - methylene - 17alpha - hydroxy-4,6-pregnadiene-3,20-dione 17-acetate |
US3737521A (en) * | 1970-12-09 | 1973-06-05 | Goodrich Co B F | Formulation for sustained release of a biological agent |
FR2271832A1 (en) * | 1974-05-22 | 1975-12-19 | Dynachim Sarl | Compsns. contg. sex hormones and their esters - for improving wt. gain in meat animals |
FR2290906A1 (fr) * | 1974-11-13 | 1976-06-11 | Dick Pierre | Nouvelles associations hormonales synergisees pour l'implantation d'animaux de boucherie |
IE56979B1 (en) * | 1984-02-14 | 1992-02-26 | Drug Systems Res & Dev | Subcutaneous implant |
US5288496A (en) * | 1990-05-15 | 1994-02-22 | Stolle Research & Development Corporation | Growth promoters for animals |
US5227167A (en) * | 1991-06-11 | 1993-07-13 | Alza Corporation | Long-term delivery device including hydrophobic loading dose |
US7767708B2 (en) * | 1998-11-04 | 2010-08-03 | Schering-Plough Animal Health Corp. | Growth stimulant compositions |
CO5140100A1 (es) * | 1998-11-04 | 2002-03-22 | Schering Corp | Composiciones estimulantes del crecimiento mejoradas el crecimiento del ganado |
US6498153B1 (en) * | 1998-12-31 | 2002-12-24 | Akzo Nobel N.V. | Extended release growth promoting two component composition |
-
2000
- 2000-02-08 US US09/500,246 patent/US20020131988A1/en not_active Abandoned
- 2000-12-04 CA CA002391957A patent/CA2391957A1/en not_active Abandoned
- 2000-12-04 NZ NZ519575A patent/NZ519575A/en unknown
- 2000-12-04 AU AU17561/01A patent/AU783538B2/en not_active Ceased
- 2000-12-04 WO PCT/US2000/030177 patent/WO2001043749A2/en active IP Right Grant
- 2000-12-04 JP JP2001544886A patent/JP2003517014A/ja not_active Withdrawn
- 2000-12-04 EP EP00980276A patent/EP1237556A2/en not_active Withdrawn
- 2000-12-04 BR BR0016012-1A patent/BR0016012A/pt not_active Application Discontinuation
- 2000-12-04 KR KR1020027007699A patent/KR100715748B1/ko not_active IP Right Cessation
- 2000-12-04 MX MXPA02005911A patent/MXPA02005911A/es active IP Right Grant
- 2000-12-15 AR ARP000106698A patent/AR026986A1/es unknown
-
2002
- 2002-05-30 ZA ZA200204352A patent/ZA200204352B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001043749A3 (en) | 2002-01-03 |
NZ519575A (en) | 2003-11-28 |
BR0016012A (pt) | 2002-07-23 |
EP1237556A2 (en) | 2002-09-11 |
WO2001043749A2 (en) | 2001-06-21 |
KR100715748B1 (ko) | 2007-05-08 |
JP2003517014A (ja) | 2003-05-20 |
US20020131988A1 (en) | 2002-09-19 |
CA2391957A1 (en) | 2001-06-21 |
AU1756101A (en) | 2001-06-25 |
AU783538B2 (en) | 2005-11-03 |
ZA200204352B (en) | 2003-10-01 |
KR20020068376A (ko) | 2002-08-27 |
MXPA02005911A (es) | 2002-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR026986A1 (es) | Implante farmaceutico con contenido de componentes de liberacion inmediata y liberacion sostenida y metodos de administracion | |
WO2018213582A8 (en) | COMPONENTS WITH HIGH API LOAD | |
NZ336511A (en) | Treating prostatic diseases using delayed and/or sustained release formulations of activated vitamin D | |
NO20061859L (no) | OROS Push Stick for kontrollert tilforsel av aktive midler | |
DE60327843D1 (de) | Arzneimittelformulierungen mit verzögerter freisetzung mit einem trägerpeptid | |
PA8526101A1 (es) | Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento | |
BRPI0412211A (pt) | composições de liberação controlada | |
BRPI0518582A2 (pt) | implante para liberaÇço de medicamento intra-ocular | |
AR048773A1 (es) | Sistema de administracion de droga (por ejemplo,dexametasona) para tratar una condicion ocular, implante bio-erosionable de liberacion prolongada comprendido en el anterior y uso de este ultimo para la fabricacion de dicho sistema de administracion de droga | |
PA8575701A1 (es) | Preparaciones acidas de insulina con estabilidad mejorada | |
BR0315700A (pt) | Dispositivo médico implantável que incorpora rapamicina deuterada para a aplicação controlada da mesma | |
BRPI0311701B8 (pt) | formulação farmacêutica de dosagem multiparticulada revestida com liberação controlada de lamotrigina | |
BR0312007A (pt) | Controle de taxa de administração transcutânea usando composições farmacêuticas amorfas | |
NO20026171L (no) | Topiske farmasöytiske formuleringer og fremgangsmåter for behandling | |
MXPA02004235A (es) | Dosificacion de farmacos a traves de la mucosa oral usando una solucion solida. | |
ATE471144T1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
BR0306513A (pt) | tampão com medicamento | |
ES2193159T3 (es) | Una formulacion de factor de coagulacion viii. | |
ES2139002T3 (es) | Terapia medicamentosa citotoxica. | |
EA200501819A1 (ru) | Способы и фармацевтические композиции для достоверного достижения приемлемых уровней тестостерона в сыворотке | |
RU2007138867A (ru) | Режимы дозирования транс-кломифена | |
SG146638A1 (en) | Pharmaceutical delivery system | |
AU1046202A (en) | Transdermal therapeutic system for treating restless-legs-syndrome | |
BRPI0607172A2 (pt) | método para a ministração de pelo menos uma substáncia farmaceuticamente ativa a um paciente, combinação de medicamentos e uso de pelo menos uma substáncia farmaceuticamente ativa para a fabricação de uma combinação de medicamentos | |
AR046146A1 (es) | Formulaciones farmaceuticas transdermicas para pulverizacion que comprenden un agente activo, un copolimero de vp/va y un vehiculo no acuoso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |